<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073863820-fd040987-6341-41a2-b0f7-d86dbd145a74/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab151</link>
            <description><![CDATA[<p class="para" id="N65541">Tumours with mutations in the <i>BRCA1</i>/<i>BRCA2</i> genes have impaired double-stranded DNA break repair, compromised replication fork protection and increased sensitivity to replication blocking agents, a phenotype collectively known as ‘BRCAness’. Tumours with a BRCAness phenotype become dependent on alternative repair pathways that are error-prone and introduce specific patterns of somatic mutations across the genome. The increasing availability of next-generation sequencing data of tumour samples has enabled identification of distinct mutational signatures associated with BRCAness. These signatures reveal that alternative repair pathways, including Polymerase θ-mediated alternative end-joining and RAD52-mediated single strand annealing are active in BRCA1/2-deficient tumours, pointing towards potential therapeutic targets in these tumours. Additionally, insight into the mutations and consequences of unrepaired DNA lesions may also aid in the identification of BRCA-like tumours lacking <i>BRCA1</i>/<i>BRCA2</i> gene inactivation. This is clinically relevant, as these tumours respond favourably to treatment with DNA-damaging agents, including PARP inhibitors or cisplatin, which have been successfully used to treat patients with BRCA1/2-defective tumours. In this review, we aim to provide insight in the origins of the mutational landscape associated with BRCAness by exploring the molecular biology of alternative DNA repair pathways, which may represent actionable therapeutic targets in in these cells.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single-molecule insight into stalled replication fork rescue in <i>Escherichia coli</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073099543-937e1f2c-1601-499f-b88a-ac3d16be86c0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab142</link>
            <description><![CDATA[<p class="para" id="N65541">DNA replication forks stall at least once per cell cycle in <i>Escherichia coli</i>. DNA replication must be restarted if the cell is to survive. Restart is a multi-step process requiring the sequential action of several proteins whose actions are dictated by the nature of the impediment to fork progression. When fork progress is impeded, the sequential actions of SSB, RecG and the RuvABC complex are required for rescue. In contrast, when a template discontinuity results in the forked DNA breaking apart, the actions of the RecBCD pathway enzymes are required to resurrect the fork so that replication can resume. In this review, we focus primarily on the significant insight gained from single-molecule studies of individual proteins, protein complexes, and also, partially reconstituted regression and RecBCD pathways. This insight is related to the bulk-phase biochemical data to provide a comprehensive review of each protein or protein complex as it relates to stalled DNA replication fork rescue.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037247915-01fe9647-a4b0-4580-af0c-3adb4c599a76/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab127</link>
            <description><![CDATA[<p class="para" id="N65541">Noncoding RNAs are functional transcripts that are not translated into proteins. They represent the largest portion of the human transcriptome and have been shown to regulate gene expression networks in both physiological and pathological cell conditions. Research in this field has made remarkable progress in the comprehension of how aberrations in noncoding RNA drive relevant disease-associated phenotypes; however, the biological role and mechanism of action of several noncoding RNAs still need full understanding. Besides fulfilling its function through sequence-based mechanisms, RNA can form complex secondary and tertiary structures which allow non-canonical interactions with proteins and/or other nucleic acids. In this context, the presence of G-quadruplexes in microRNAs and long noncoding RNAs is increasingly being reported. This evidence suggests a role for RNA G-quadruplexes in controlling microRNA biogenesis and mediating noncoding RNA interaction with biological partners, thus ultimately regulating gene expression. Here, we review the state of the art of G-quadruplexes in the noncoding transcriptome, with their structural and functional characterization. In light of the existence and further possible development of G-quadruplex binders that modulate G-quadruplex conformation and protein interactions, we also discuss the therapeutic potential of G-quadruplexes as targets to interfere with disease-associated noncoding RNAs.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ADP-ribosylation of RNA and DNA: from <i>in vitro</i> characterization to <i>in vivo</i> function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036748486-813c75d2-bd64-4940-bb04-215221e21b47/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab136</link>
            <description><![CDATA[<p class="para" id="N65541">The functionality of DNA, RNA and proteins is altered dynamically in response to physiological and pathological cues, partly achieved by their modification. While the modification of proteins with ADP-ribose has been well studied, nucleic acids were only recently identified as substrates for ADP-ribosylation by mammalian enzymes. RNA and DNA can be ADP-ribosylated by specific ADP-ribosyltransferases such as PARP1–3, PARP10 and tRNA 2′-phosphotransferase (TRPT1). Evidence suggests that these enzymes display different preferences towards different oligonucleotides. These reactions are reversed by ADP-ribosylhydrolases of the macrodomain and ARH families, such as MACROD1, TARG1, PARG, ARH1 and ARH3. Most findings derive from <i>in vitro</i> experiments using recombinant components, leaving the relevance of this modification in cells unclear. In this Survey and Summary, we provide an overview of the enzymes that ADP-ribosylate nucleic acids, the reversing hydrolases, and the substrates’ requirements. Drawing on data available for other organisms, such as pierisin1 from cabbage butterflies and the bacterial toxin–antitoxin system DarT–DarG, we discuss possible functions for nucleic acid ADP-ribosylation in mammals. Hypothesized roles for nucleic acid ADP-ribosylation include functions in DNA damage repair, in antiviral immunity or as non-conventional RNA cap. Lastly, we assess various methods potentially suitable for future studies of nucleic acid ADP-ribosylation.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanisms of damage tolerance and repair during DNA replication]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021000419-4ea814ea-6cad-46a0-be40-0635eeed5e44/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab101</link>
            <description><![CDATA[<p class="para" id="N65541">Accurate duplication of chromosomal DNA is essential for the transmission of genetic information. The DNA replication fork encounters template lesions, physical barriers, transcriptional machinery, and topological barriers that challenge the faithful completion of the replication process. The flexibility of replisomes coupled with tolerance and repair mechanisms counteract these replication fork obstacles. The cell possesses several universal mechanisms that may be activated in response to various replication fork impediments, but it has also evolved ways to counter specific obstacles. In this review, we will discuss these general and specific strategies to counteract different forms of replication associated damage to maintain genomic stability.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Staying true to yourself: mechanisms of DNA methylation maintenance in mammals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020897814-f061fce0-78fe-4159-83dc-c58ad2d4476e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1154</link>
            <description><![CDATA[<p class="para" id="N65541">DNA methylation is essential to development and cellular physiology in mammals. Faulty DNA methylation is frequently observed in human diseases like cancer and neurological disorders. Molecularly, this epigenetic mark is linked to other chromatin modifications and it regulates key genomic processes, including transcription and splicing. Each round of DNA replication generates two hemi-methylated copies of the genome. These must be converted back to symmetrically methylated DNA before the next S-phase, or the mark will fade away; therefore the maintenance of DNA methylation is essential. Mechanistically, the maintenance of this epigenetic modification takes place during and after DNA replication, and occurs within the very dynamic context of chromatin re-assembly. Here, we review recent discoveries and unresolved questions regarding the mechanisms, dynamics and fidelity of DNA methylation maintenance in mammals. We also discuss how it could be regulated in normal development and misregulated in disease.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ionic liquids: prospects for nucleic acid handling and delivery]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906645822-753cc2d8-27bc-4c8a-8658-b6ab4f4faa6d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1280</link>
            <description><![CDATA[<p class="para" id="N65541">Operations with nucleic acids are among the main means of studying the mechanisms of gene function and developing novel methods of molecular medicine and gene therapy. These endeavours usually imply the necessity of nucleic acid storage and delivery into eukaryotic cells. In spite of diversity of the existing dedicated techniques, all of them have their limitations. Thus, a recent notion of using ionic liquids in manipulations of nucleic acids has been attracting significant attention lately. Due to their unique physicochemical properties, in particular, their micro-structuring impact and tunability, ionic liquids are currently applied as solvents and stabilizing media in chemical synthesis, electrochemistry, biotechnology, and other areas. Here, we review the current knowledge on interactions between nucleic acids and ionic liquids and discuss potential advantages of applying the latter in delivery of the former into eukaryotic cells.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Splicing at the phase-separated nuclear speckle interface: a model]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765835123224-5077edf5-9f62-4b5e-9184-197d898dcb08/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1209</link>
            <description><![CDATA[<p class="para" id="N65541">Phase-separated membraneless bodies play important roles in nucleic acid biology. While current models for the roles of phase separation largely focus on the compartmentalization of constituent proteins, we reason that other properties of phase separation may play functional roles. Specifically, we propose that interfaces of phase-separated membraneless bodies could have functional roles in spatially organizing biochemical reactions. Here we propose such a model for the nuclear speckle, a membraneless body implicated in RNA splicing. In our model, sequence-dependent RNA positioning along the nuclear speckle interface coordinates RNA splicing. Our model asserts that exons are preferentially sequestered into nuclear speckles through binding by SR proteins, while introns are excluded through binding by nucleoplasmic hnRNP proteins. As a result, splice sites at exon-intron boundaries are preferentially positioned at nuclear speckle interfaces. This positioning exposes splice sites to interface-localized spliceosomes, enabling the subsequent splicing reaction. Our model provides a simple mechanism that seamlessly explains much of the complex logic of splicing. This logic includes experimental results such as the antagonistic duality between splicing factors, the position dependence of splicing sequence motifs, and the collective contribution of many motifs to splicing decisions. Similar functional roles for phase-separated interfaces may exist for other membraneless bodies.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Factors that mold the nuclear landscape of HIV-1 integration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824654370-384f382c-a329-4c3c-be55-1a6e1c26ea50/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1207</link>
            <description><![CDATA[<p class="para" id="N65541">The integration of retroviral reverse transcripts into the chromatin of the cells that they infect is required for virus replication. Retroviral integration has far-reaching consequences, from perpetuating deadly human diseases to molding metazoan evolution. The lentivirus human immunodeficiency virus 1 (HIV-1), which is the causative agent of the AIDS pandemic, efficiently infects interphase cells due to the active nuclear import of its preintegration complex (PIC). To enable integration, the PIC must navigate the densely-packed nuclear environment where the genome is organized into different chromatin states of varying accessibility in accordance with cellular needs. The HIV-1 capsid protein interacts with specific host factors to facilitate PIC nuclear import, while additional interactions of viral integrase, the enzyme responsible for viral DNA integration, with cellular nuclear proteins and nucleobases guide integration to specific chromosomal sites. HIV-1 integration favors transcriptionally active chromatin such as speckle-associated domains and disfavors heterochromatin including lamina-associated domains. In this review, we describe virus-host interactions that facilitate HIV-1 PIC nuclear import and integration site targeting, highlighting commonalities among factors that participate in both of these steps. We moreover discuss how the nuclear landscape influences HIV-1 integration site selection as well as the establishment of active versus latent virus infection.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Basic mechanisms and kinetics of pause-interspersed transcript elongation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761809375-b3a5acd0-dfd4-4772-a46e-36c5dff96a51/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1182</link>
            <description><![CDATA[<p class="para" id="N65541">RNA polymerase pausing during elongation is an important mechanism in the regulation of gene expression. Pausing along DNA templates is thought to be induced by distinct signals encoded in the nucleic acid sequence and halt elongation complexes to allow time for necessary co-transcriptional events. Pausing signals have been classified as those producing short-lived elemental, long-lived backtracked, or hairpin-stabilized pauses. In recent years, structural microbiology and single-molecule studies have significantly advanced our understanding of the paused states, but the dynamics of these states are still uncertain, although several models have been proposed to explain the experimentally observed pausing behaviors. This review summarizes present knowledge about the paused states, discusses key discrepancies among the kinetic models and their basic assumptions, and highlights the importance and challenges in constructing theoretical models that may further our biochemical understanding of transcriptional pausing.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item>
    </channel>
</rss>